Skip to main content
Premium Trial:

Request an Annual Quote

ReadCoor Wins $2.5M Gates Grant for FISSEQ Pathogen Detection Technology

NEW YORK (GenomeWeb) ­– Sequencing platform developer ReadCoor has been awarded a $2.5 million, two-year grant from the Bill and Melinda Gates Foundation to develop the infectious disease detection capabilities of its tissue-based fluorescent in situ sequencing (FISSEQ ) technology.

The Gates funding will support development of FISSEQ-based diagnostics and analytical tools specifically targeting pathogens associated with early childhood diseases and epidemics, the firm said. An aim of ReadCoor's in situ approach is also to create a disease atlas based on FISSEQ's comprehensive view of interactions between cells and tissues.

"We are committed to applying the FISSEQ platform for the benefit of humankind and we applaud the Gates Foundation for its vision and willingness to support innovative approaches to age-old problems," ReadCoor Co-Founder and CEO Shawn Marcell said in a statement.

A spinout of the Wyss Institute for Biologically Inspired Engineering at Harvard University, the firm raised $23 million in Series A funding earlier this year. ReadCoor has said it will offer the proprietary FISSEQ technology as a service, and plans to develop a platform for in situ sequencing.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.